EULAR 2007 News

Conventional Drugs Can Beat Back Early RA
July 3, 2007
Two-year data show that intensive treatment with methotrexate (MTX) and intra-articular corticosteroid can reduce X-ray progression in early RA...

RA Disease Activity Decreases During Pregnancy, but Less Than Was Assumed
June 28, 2007
A prospective study of RA outcomes during pregnancy shows that improvement and remission rates are not as high as previously reported…

Zoledronate Reduces Bone Turnover, Preserves Bone Quality
June 28, 2007
Once-yearly zoledronate infusion both reduces bone turnover and preserves trabecular bone structure…

NSAID Stroke Risk Related to Hypertensive Effect, Not COX-2 Selectivity; Coxib GI Safety Advantage Depends on Comparator NSAID
June 26, 2007
Stroke risk is increased with NSAIDs known to cause hypertension, regardless of their COX-2 selectivity, and the apparent GI safety of some coxibs may be largely a function of the comparator NSAID used in clinical trials…

Belimumab Improves Symptoms in Nearly Half of Lupus Patients at 52 Weeks, Advances to Phase III Studies
June 22, 2007
Belimumab produces sustained improvement in SLE symptoms…

Lumiracoxib Effective for Hip OA and Better for BP Control Than Ibuprofen in Hypertensive OA Patients
June 21, 2007
Lumiracoxib shows promise for hip OA, and may be better than ibuprofen for hypertensive OA patients...

Early Data Show That Experimental B-Cell Blocker Passes Muster
June 21, 2007
Ofatumumab (Humax-CD20^TM), an experimental B-cell depleting agent, may be a safe and effective treatment for RA, but how it compares to rituximab remains to be seen...